Clinical trial
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
NCT01091454
Study timeline
Study start (actual)2010-06-01Date precision: month
Registry last updated2018-05-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple-negative Breast Cancerunresolved
Interventions
brostallicinDRUG
cisplatinDRUG · verified · RxNorm: cisplatin
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
HonoluluHawaii, United States7DenverColorado, United States6ToledoOhio, United States6Des MoinesIowa, United States6ColumbusOhio, United States5OmahaNebraska, United States5WichitaKansas, United States5DaytonOhio, United States5PeoriaIllinois, United States5Green BayWisconsin, United States4Grand RapidsMichigan, United States3BillingsMontana, United States3
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01091454 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.